ARCHIVES

NCI Advisors Approve $20.5M Program Of Grants, Contracts For Biospecimen Research.

This article is from The Cancer Letter archive.

Vol. 33 No. 26 | July 6, 2007

Download PDF Visit The Full Archive

Related Articles

Radiation Oncologist Objects To ACR Comments Results

November 27, 1981

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

Funding opportunties listed.

December 3, 2004